Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
Milica Z StevanovićDepartment of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0003-1961-737X
Sofija S BekićDepartment of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0002-9020-698X
Edward T PetriDepartment of Biology & Ecology, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia.ORCID 0000-0002-3650-1523
Andjelka S ĆelićDepartment of Biology & Ecology, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia.ORCID 0000-0002-1058-6872
Dimitar S JakimovOncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Put Dr Goldmana 4, 21204 Sremska Kamenica, Serbia.ORCID 0000-0002-1747-4718
Marija N SakačDepartment of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0002-2796-1296
Ivana Z KuzminacDepartment of Chemistry, Biochemistry & Environmental Protection, University of Novi Sad, Faculty of Sciences, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia.ORCID 0000-0001-8045-3568
University of Novi Sad · RS
Funding
Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina 142-451-3463/2023-01the Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200125 and 451-03-65/2024-03/200
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsCell ProliferationDrug Screening Assays, AntitumorMolecular Docking SimulationAldo-Keto Reductase Family 1 Member C3AromataseCell Line, TumorEstrogen Receptor alphaHumansMolecular StructureReceptors, AndrogenStructure-Activity RelationshipAKR1C3 protein, humanAldo-Keto Reductase Family 1 Member C3Antineoplastic AgentsAromataseEstrogen Receptor alphaReceptors, Androgen2-picolyl steroidsaldo-keto reductaseantiproliferative activityaromatasehormone receptorsin silico ADMEmolecular dockingpicolinylidene
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.